Veracyte (VCYT) Tops Q2 EPS by 3c

Veracyte (NASDAQ: VCYT) reported Q2 EPS of ($0.12), $0.03 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $90.3 million versus the consensus estimate of $83.08 million.

For earnings history and earnings-related data on Veracyte (VCYT) click here.

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• Citi sees this stock as primary lithium demand beneficiary, upgrades to Buy
• Accenture (ACN) Tops Q3 EPS by 8c, Misses on Revenue; Offers FY26 EPS Guidance